Skip to main navigation Skip to search Skip to main content

RNAe in a transgenic growth hormone mouse model shows potential for use in gene therapy

  • Haizhou Long
  • , Yi Yao
  • , Shouhong Jin
  • , Yingting Yu
  • , Xiongbing Hu
  • , Fengfeng Zhuang
  • , Hanshuo Zhang
  • , Qiong Wu*
  • *Corresponding author for this work
  • Tsinghua University
  • ViewSolid Biotech
  • GenoArray Biotech

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: RNAe is a new method that enhances protein expression at the post-transcriptional level. RNAe utility was further explored to improve endogenous protein expression. Results: Transgenic mice were created by targeting RNAe to growth hormone gene into the C57/BL mouse genome by transposon mediated integration; the mice showed a heavier body weight and longer body length compared with normal mice. RNAe can also be used for gene therapy through the delivery of in vitro transcribed RNA. Conclusion: This study takes a further step towards applying RNAe in pharmaceutical approaches by transposon-based transgenic mice model construction and the use of in vitro transcribed RNA transfection assay.

Original languageEnglish
Pages (from-to)179-188
Number of pages10
JournalBiotechnology Letters
Volume39
Issue number2
DOIs
StatePublished - 1 Feb 2017
Externally publishedYes

Keywords

  • Growth hormone
  • Pharmaceutical application
  • Protein production
  • RNAe
  • Transgenic mice

Fingerprint

Dive into the research topics of 'RNAe in a transgenic growth hormone mouse model shows potential for use in gene therapy'. Together they form a unique fingerprint.

Cite this